Evidence map›Paper›PMID 23392570›Full record

ReviewJournal of mammary gland biology and neoplasia2013

Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Leena Hilakivi-Clarke, Sonia de Assis, Anni Warri

Open access · greenAbstract readReview
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Leena Hilakivi-ClarkeDepartment of Oncology, Georgetown University, Washington, DC 20057, USA. clarkel@georgetown.edu
Sonia de Assis
Anni Warri
Georgetown University · USUniversity of Turku · FI

Funding

TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Timing of dietary exposure and breast cancer riskU54CA100970 · NCI · GEORGETOWN UNIVERSITY · PI HILAKIVI-CLARKE, LEENA A. · 2003 to 2008
$7.2M
Novel Targets in Endocrine ResponsivenessU54CA149147 · NCI · GEORGETOWN UNIVERSITY · PI CLARKE, ROBERT R. · 2010 to 2014
$6.9M
Transgenerational effects of maternal high fat diet during pregnancy on breast caR01CA164384 · NCI · GEORGETOWN UNIVERSITY · PI HILAKIVI-CLARKE, LEENA A. · 2012 to 2015
$2.0M
In utero estrogenic exposures and transgenerational risk for breast cancerR03CA150040 · NCI · GEORGETOWN UNIVERSITY · PI DE ASSIS, SONIA · 2010 to 2011
$151k
STATISTICAL PROBLEMS IN COMMUNITY INTERVENTION STUDIESR03CA051668 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MICKEY, RUTH · 1989 to 1989
–
NCI NIH HHS P30 CA051668NCI NIH HHS R01 CA164384NCI NIH HHS R01 CA164384-01A1NCI NIH HHS R03 CA150040NCI NIH HHS T32 CA009686NCI NIH HHS U54 CA100970NCI NIH HHS U54 CA149147NCI NIH HHS U54CA149147
6 · The paper itself

Abstract

Women are using estrogens for many purposes, such as to prevent pregnancy or miscarriage, or to treat menopausal symptoms. Estrogens also have been used to treat breast cancer which seems puzzling, since there is convincing evidence to support a link between high lifetime estrogen exposure and increased breast cancer risk. In this review, we discuss the findings that maternal exposure to the synthetic estrogen diethylstilbestrol during pregnancy increases breast cancer risk in both exposed mothers and their daughters. In addition, we review data regarding the use of estrogens in oral contraceptives and as postmenopausal hormone therapy and discuss the opposing effects on breast cancer risk based upon timing of exposure. We place particular emphasis on studies investigating how maternal estrogenic exposures during pregnancy increase breast cancer risk among daughters. New data suggest that these exposures induce epigenetic modifications in the mammary gland and germ cells, thereby causing an inheritable increase in breast cancer risk for multiple generations.

Indexed as

AgingAnimalsBreast NeoplasmsCarcinogensContraceptives, Oral, HormonalDiethylstilbestrolEndocrine DisruptorsEnvironmental ExposureEpigenesis, GeneticEstradiol CongenersEstrogen Replacement TherapyEstrogens, Non-SteroidalFemaleFetal DevelopmentHumansMammary Glands, AnimalCarcinogensContraceptives, Oral, HormonalDiethylstilbestrolEndocrine DisruptorsEstradiol CongenersEstrogens, Non-Steroidal

Identifiers

PMID23392570
PMCPMC3635108
OpenAlexW2073938931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.